跳至主要内容
临床试验/CTRI/2022/08/044530
CTRI/2022/08/044530已完成3 期

Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain–A single blinded randomized study - BOTOX

AIIMS Bhubaneswar0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with chronic low back pain > 3 months
  • 2. Without red flags (history suggestive of tumor, trauma, infection, malignancy or cauda equina syndrome),
  • 3.Aged between 18-60 years
  • 4. Willing to participate
  • Will be investigated with calcium, Vit D and X rays

排除标准

  • Acute low back pain,
  • Known systemic disorders,
  • Spinal deformities
  • Neuromuscular weakness
  • Malignancy
  • Bleeding disorders
  • History of back surgeries
  • Known allergies to the BoNT-A

研究者

相似试验

Botulinum Toxin for Treating Low Back Pai | 临床试验